WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark MABLINK was filed as Word mark on 07/15/2020 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1564321 |
| Countries | 
|
| Base trademark |
No. 4614472,
January 15, 2020
|
| Application date | July 15, 2020 |
| Expiration date | July 15, 2030 |
Trademark owner
14 rue Waldeck-Rousseau
F-69006 LYON
FR
F-69006 LYON
FR
Trademark representatives
235 cours Lafayette
F-69006 LYON
FR
goods and services
01
Chemical, biochemical, biological and biotechnological
preparations; chemical substances for the manufacture of
pharmaceutical products; chemical substances for tethering
molecules, in particular chemical substances for tethering
molecules for cancer therapy, for research in active
substances and medicines; chemical substances for the
formation of antibody conjugates; chemical reagents for
scientific purposes other than for medical or veterinary
purposes; reagents for scientific or medical research;
chemical, biochemical and biological reagents; chemicals
for bioconjugation, reversible cysteine protection, surface
modification, and the production of prodrugs; antibodies and
antibody conjugates for scientific purposes, other than for
medical or veterinary purposes; antibodies for scientific or
medical research; molecules and biomolecules, especially
reagents, antibody fragments, antibodies, all intended for
fundamental research and development, medical research and
scientific diagnosis; Diagnostic products for scientific or
research use related to conjugated antibodies (medicines)
05
Pharmaceutical preparations; pharmaceutical products, in
particular for the prevention or treatment of human
diseases; chemical, biological and biochemical products for
medical and pharmaceutical use, especially, antibody-drug
conjugates or any protein combined with a drug, a
polynucleotide, another protein, a chemical entity, or
another functional entity, or these products used as binders
or fillers; pharmaceutical preparations, in particular
bioconjugates, intended for the diagnosis and treatment of
diseases; antibody products, especially, antibody or protein
bioconjugates for the medical diagnosis and treatment of
diseases, including antibody/protein drug conjugates,
antibody/protein labeled conjugates and antibody/protein
imaging agent conjugates; delivery devices for antibodies;
molecules and biomolecules, especially, reagents, antibody
fragments, antibodies, all intended for medical diagnosis
and disease treatment; pharmaceutical products,
preparations and medical articles, especially antibodies,
antibody conjugates and active principles and antibody
conjugates; chemical reagents for medical use, in
particular chemical reagents to bind molecules for medical
use; chemical reagents for the functionalization of
biomolecules for medical use
40
Preparation, transformation, processing of biopharmaceutical
materials and especially reagents, antibodies and conjugated
antibodies; processing and transformation of
biopharmaceutical materials on behalf of third parties;
custom manufacturing of scientific, medical, chemical,
biochemical and pharmaceutical products
42
Scientific research; biological and chemical research;
biochemical research and development; research and
development in the pharmaceutical, biomedical and
biotechnological fields, especially research into
antibodies, including conjugated antibodies; research and
development in the fields of biological development and
biomanufacturing; laboratory research, analysis,
evaluation, development and clinical testing of therapeutic,
preventive and diagnostic compositions and treatments;
conducting scientific and medical research for third
parties; consultancy in the field of pharmaceutical
research, chemistry, biotechnology; custom synthesis of
chemical substances; chemical and/or biological development
services; services of a chemical and/or a biologist;
chemical and biological laboratory services; laboratory
services concerning the modification and production of
reagents, antibodies and conjugated antibodies; research
and development services in the field of reagent development
and production of antibodies and conjugated antibodies;
conducting chemical and/or biological analyses; customized
design and development of chemical reagents, antibodies and
conjugated antibodies; development of chemical substances,
in particular chemical substances to tether molecules and in
particular technological platforms in the form of or used
for the creation or improvement of antibody-drug conjugates
or any protein combined with a drug, a polynucleotide,
another protein, a chemical entity or another functional
entity intended for industry and science
44
Medical services; medical modification of antibodies;
medical services in the field of personalized medicine;
advice and information services with respect to
biopharmaceutical products; pharmaceutical advice;
consultancy services in the field of medicine
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 4, 2022 | 2022/27 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| May 12, 2022 | 2022/20 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| April 18, 2022 | 2022/16 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| April 5, 2022 | 2022/14 Gaz | CA | Rejection |
| January 3, 2022 | 2022/1 Gaz | KR | Rejection |
| November 16, 2021 | 2021/46 Gaz | BR | Rejection |
| November 4, 2021 | 2021/44 Gaz | JP | Rejection |
| June 24, 2021 | 2021/27 Gaz | RAW: Limitation | |
| May 3, 2021 | 2021/19 Gaz | IN | Rejection |
| April 28, 2021 | 2021/17 Gaz | EM | Rejection |
| March 16, 2021 | 2021/13 Gaz | CN | Rejection |
| January 5, 2021 | 2021/1 Gaz | US | Rejection |
| July 15, 2020 | 2020/48 Gaz | FR | Registration |
ID: 141564321